Viewing Study NCT05093933


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-05-29 @ 6:40 AM
Study NCT ID: NCT05093933
Status: COMPLETED
Last Update Posted: 2025-12-19
First Post: 2021-10-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1242-035
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators